Catalyst Pharmaceuticals Inc (CPRX)
15.12
-0.22
(-1.47%)
USD |
NASDAQ |
Apr 19, 16:00
15.13
+0.02
(+0.10%)
After-Hours: 20:00
Catalyst Pharmaceuticals Gross Profit Margin (Quarterly): 85.70% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.70% |
| September 30, 2023 | 86.20% |
| June 30, 2023 | 87.90% |
| March 31, 2023 | 88.35% |
| December 31, 2022 | 81.57% |
| September 30, 2022 | 83.12% |
| June 30, 2022 | 85.61% |
| March 31, 2022 | 86.33% |
| December 31, 2021 | 80.82% |
| September 30, 2021 | 85.23% |
| Date | Value |
|---|---|
| June 30, 2021 | 87.50% |
| March 31, 2021 | 84.50% |
| December 31, 2020 | 84.30% |
| September 30, 2020 | 86.77% |
| June 30, 2020 | 86.02% |
| March 31, 2020 | 85.75% |
| December 31, 2019 | 85.40% |
| September 30, 2019 | 85.80% |
| June 30, 2019 | 85.22% |
| March 31, 2019 | 86.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.82%
Minimum
Dec 2021
88.35%
Maximum
Mar 2023
85.37%
Average
85.70%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 46.92% |
| Sarepta Therapeutics Inc | 88.87% |
| PTC Therapeutics Inc | 90.52% |
| Corcept Therapeutics Inc | 98.61% |
| Cytokinetics Inc | -4.98K% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.45% |
| Return on Assets | 16.92% |
| Return on Invested Capital | 20.45% |
| Profit Margin (Quarterly) | 31.51% |
| Operating Margin (Quarterly) | 37.71% |
| Return on Net Operating Assets | 33.73% |